Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 77 points (-0.4%) at 17,034 as of Tuesday, Sept. 9, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 824 issues advancing vs. 2,132 declining with 162 unchanged. The Health Care sector currently sits down 0.2% versus the S&P 500, which is down 0.3%. Top gainers within the sector include HCA Holdings ( HCA), up 2.6%, Universal Health Services ( UHS), up 2.6%, Novo Nordisk A/S ( NVO), up 2.4%, AbbVie ( ABBV), up 2.1% and Covidien ( COV), up 1.9%. On the negative front, top decliners within the sector include Illumina ( ILMN), down 1.4%, Celgene ( CELG), down 1.1%, Biogen Idec ( BIIB), down 0.9%, Amgen ( AMGN), down 0.8% and Pfizer ( PFE), down 0.7%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. Tenet Healthcare ( THC) is one of the companies pushing the Health Care sector higher today. As of noon trading, Tenet Healthcare is up $2.84 (4.8%) to $61.83 on heavy volume. Thus far, 1.5 million shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $59.42-$62.37 after having opened the day at $59.69 as compared to the previous trading day's close of $58.99. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Tenet Healthcare Corporation, an investor-owned health care services company, primarily operates acute care hospitals and related health care facilities in the United States. Tenet Healthcare has a market cap of $5.7 billion and is part of the health services industry. Shares are up 40.0% year-to-date as of the close of trading on Monday. Currently there are 9 analysts who rate Tenet Healthcare a buy, 1 analyst rates it a sell, and 5 rate it a hold. TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins. Get the full Tenet Healthcare Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.